PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF MUCOLIPIDOSIS II, COMPRISING A LYSOSOMAL ENZYME AS AN ACTIVE INGREDIENT

The present invention relates to a pharmaceutical composition comprising a lysosomal enzyme as an active ingredient for preventing or treating mucolipidosis II, wherein the lysosomal enzyme is derived from human placenta. The composition improves clinical findings of mucolipidosis II, and thus can b...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	LEE, SUNG YOUL, PARK, SUNG ICK
Format:	Patent
Sprache:	eng ; kor
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to a pharmaceutical composition comprising a lysosomal enzyme as an active ingredient for preventing or treating mucolipidosis II, wherein the lysosomal enzyme is derived from human placenta. The composition improves clinical findings of mucolipidosis II, and thus can be valuably used for preventing or treating mucolipidosis II.